A Study of OKI-179 in Patients With Solid Tumors

NCT03931681 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: OKI-179

Sponsor

OnKure, Inc.

Collaborators

[object Object]